Cowen Analyst Likes Intercept Pharmaceuticals, ACADIA Pharmaceuticals And Raptor Pharmaceutical

By: via Benzinga
Speaking on CNBC's Fast Money, Ritu Baral of Cowen and Company said that Intercept Pharmaceuticals Inc (NASDAQ: ICPT) is a buy. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.